NSE - SMEListed
Infinium Pharmachem Limited
Company websiteInfinium Pharmachem Limited seeks to raise ₹18,75,000 crore — fresh issue ₹18,75,000 crore, OFS ₹0 crore. Total shares offered: 1000.
Subscribe between 31-03-2023 and 05-04-2023. Allotment is expected on 11-04-2023, with listing on 17-04-2023. Action tip: if you’re unsure, consider starting with a small allocation and review the company’s prospectus.
Start Date31-03-2023
End Date05-04-2023
Listing Date17-04-2023
Allotment Date11-04-2023
Current Price₹141.50
GMP₹0 (0.00%)
Lot Size1000 Shares
Subscription1.84 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹135 - ₹135
Pre Issue₹50,83,060
Post Issue₹69,58,060
Issue Size₹18,75,000
(aggregating up to 25.26 Cr)
(aggregating up to 25.26 Cr)
Fresh Issue₹18,75,000
(aggregating up to 25.26 Cr)
(aggregating up to 25.26 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Infinium Pharmachem Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹135 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
11 Nov 2025, 12:57 | ₹135 | ₹0 | ₹135 (0.00%) |
21 Mar 2025, 07:33 | ₹135 | ₹0 | ₹135 (0.00%) |
Financials overview In Lakhs
Here is a quick look at the recent financial performance of Infinium Pharmachem Limited . The numbers below ( In Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
Total | 0 | 0 | 0.00 |
The IPO reservation for Infinium Pharmachem Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Market Maker | 5.01% | 94,000 |
NII (HNI) | 46.40% | 8,70,000 |
RETAIL | 46.40% | 8,70,000 |
Employee | 2.19% | 41,000 |
TOTAL | 100.00% | 18,75,000 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 1,000 | ₹1,35,000 | |
HNI | 2 | 2,000 | ₹2,70,000 |
Below you can find the official contact details of Infinium Pharmachem Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: info@infiniumpharmachem.com
Phone: +91-2692-238849
Website: https://infiniumpharmachem.com/
Address: 38 G.I.D.C Sojitra, Taluka - Sojitra, Dist. - Anand - 387240
IPO Registrar
Name: Bigshare Services Private Limited
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://www.bigshareonline.com/